The Journal of urology
Immune checkpoint inhibitors for high-risk non-muscle invasive bladder cancer: Lessons learnt from the CREST and POTOMAC trials.
Daniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
Published: 202510.1097/JU.0000000000004864
No abstract available for this study.